Show
Sort by
-
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer
-
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer : analysis of the phase III SOLO2/ENGOT-Ov21 study
-
Clear cell carcinoma of the endometrium
-
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria
-
- Journal Article
- A1
- open access
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer
-
- Journal Article
- A1
- open access
Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer : a systematic review
-
Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol
-
Increased incidence of ovarian cancer in both endometriosis and adenomyopsis
-
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer
-
The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer; A systematic review